Pfizer Inc (USD)
PFE
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range36.62 | 37.00
52-Wk Range- | -
Last Close-
Mkt Cap (m)-
Dividend yield-
ISINUS7170811035
Volume33,388,145.00
Exchange VenueNYS

Company Profile

Pfizer Inc is a biopharmaceutical company that discovers, develops, manufactures, and markets healthcare products including medicines, and vaccines as well as many of the consumer healthcare products.

Key Information
Price/Earning-
Price/Book-
Price/Sales-
P/CF-
Rev Growth (3 year avg)-
EPS Growth (3 year avg)-
Operating Margin % -
Net Margin %-
Return on Equity-
Debt/Equity-

Documents

Prospectus
en 20/05/2020
Annual Report
en 31/12/2019

Please refer to the below issuer website for further documents.

https://www.pfizer.com

Financials

Income Statement
USD201520162017201820192020
Revenue (m)48,851.0052,824.0052,546.0053,647.0051,750.00-
Operating Income (m)12,976.0013,730.0014,107.0015,045.0013,921.00-
Net Income (m)6,960.007,215.0021,308.0011,153.0016,273.00-
Basic EPS1.131.183.571.902.92-
Avg. Diluted Shares Outstanding (m)6,257.006,159.006,058.005,977.005,675.00-
Balance Sheet
USD201520162017201820192020
Current Assets (m)43,804.0038,949.0041,141.0049,926.0032,803.00-
Non Current Assets (m)123,658.00132,666.00130,654.00109,497.00134,685.00-
Total Assets (m)167,460.00171,615.00171,797.00159,422.00167,489.00-
Current Liabilities (m)29,399.0031,115.0030,427.0031,858.0037,304.00-
Total Liabilities (m)------
Total Equity (m)64,720.0059,544.0071,308.0063,407.0063,143.00-
Cash Flows
USD201520162017201820192020
Operating Cash Flows (m)14,512.0015,901.0016,470.0015,827.0012,588.00-
Capital Expenditure (m)-1,496.00-1,999.00-2,217.00-2,196.00-2,594.00-
Figures are quoted in USD unless stated otherwise
$
36.73
Last Price